Similarly, another study using ovarian cancer mouse models showed that treatment with the chemotherapy agents topotecan and paclitaxel resulted in increased survival of mice following the rAAV-mediated expression of bevacizumab, a monoclonal antibody directed towards VEGF, resulting in decreased angiogenesis [31]. Here, VEGFA is linked to ovarian cancer.